TrialInternational journal of clinical practice2008

Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions.

D R Staskin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.